INS and primary adrenal insufficiency: It is estimated that the prevalence of Addison’s disease in T1D is 0.3%.2 Therefore, glucocorticoid replacement must be carefully tailored and monitored closely to minimize hypoglycemic episodes and use insulin therapy safely.